Where is the live CopyMark page for USPTO serial 78452717?

The live record is at https://getcopymark.com/trademark/78452717. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns PHENTRAMINE?

According to the public USPTO record for serial number 78452717, the listed owner(s) include: Pharmaceautical Grade HealthProducts, LLC.

What is USPTO serial number 78452717?

Serial number 78452717 is the USPTO application identifier for the mark PHENTRAMINE. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover PHENTRAMINE?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: PHENTRAMINE Serial# 78452717 | status 614; last event PETD | Trademark Info & Attorney Guidance

Q: What is the current status of PHENTRAMINE?

PHENTRAMINE (78452717) currently shows USPTO status code 614 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHENTRAMINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Pharmaceautical Grade HealthProducts, LLC
marietta, GA
Other trademarks owned by Pharmaceautical Grade HealthProducts, LLC

Goods and services

Class	Description	Status	First use
005	Phentramine is a non prescription weight control aid that is a proprietary blend made for Pharmaceautical Grade Health Products, LLC	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Mar 15, 2006	PETD	PETITION TO REVIVE-DENIED	—
Jan 9, 2006	PINM	INCOMPLETE PETITION NOTICE MAILED	—
Nov 18, 2005	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Nov 17, 2005	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Nov 17, 2005	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2005	PROA	TEAS PETITION TO REVIVE RECEIVED	—
Sep 26, 2005	MAB2	ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 26, 2005	ABN2	ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 21, 2005	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2005	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2005	DOCK	ASSIGNED TO EXAMINER	—
Jul 28, 2004	NWAP	NEW APPLICATION ENTERED	—

PHENTRAMINE